一种选择性不可逆转的抑制剂,向PDZ蛋白相互作用域
Naoaki Fujii1, Jose J Haresco, Kathleen A P Novak
1Department of Pharmaceutical Chemistry, University of California at San Francisco, Genentech Hall, Mission Bay, 600 16th Street 2280, San Francisco, California 94143-2280, USA.
Journal of the American Chemical Society
|October 2, 2003
概括
研究人员开发了一种针对蛋白相互作用的新型不可逆转的抑制剂,特别是MAGI3 PDZ域. 这一突破使得研究蛋白质-蛋白质相互作用和释放PTEN成为可能,从而提高PKB通路的调节.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 不可逆转的蛋白酶抑制剂是研究酶活性和功能的宝贵工具.
- 设计蛋白质与蛋白质相互作用的不可逆转抑制剂,特别是针对PDZ等特定领域,由于缺乏机械原理,因此存在挑战.
研究的目的:
- 报告第一个基于机制的不可逆转抑制剂,针对特定蛋白质相互作用,重点关注MAGI3.3的第二个PDZ域.
- 证明该抑制剂在研究PTEN和MAGI3之间的相互作用及其对细胞信号的下游影响中的实用性.
主要方法:
- 使用计算评估设计一种不可逆转的抑制剂的理性设计,利用MAGI3 PDZ域中保存的histidine残留物.
- 在体外测试以描述抑制剂的特性及其对PTEN-MAGI3相互作用的影响.
- 基于细胞的实验评估抑制剂对PTEN释放和PKB信号通路激活的影响.
主要成果:
- 一种新的不可逆转的抑制剂成功设计和合成,向MAGI3 PDZ域.
- 该化合物在体外证明了PTEN-MAGI3相互作用的不可逆转的抑制.
- 在细胞模型中,抑制剂从MAGI3释放了PTEN,并导致PKB信号通路的上调.
结论:
- 这项研究提出了第一个基于机制的不可逆转的蛋白相互作用抑制剂,专门针对MAGI3 PDZ域.
- 开发的抑制剂作为一个强大的工具来剖析PTEN-MAGI3相互作用在生理过程中的功能作用.
- 这些发现通过调节蛋白质-蛋白质相互作用和相关的信号通路,为治疗策略开辟了新的途径.
相关概念视频
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...